Increased B-cell activating factor (BAFF)/B-lymphocyte stimulator (BLyS) in primary antiphospholipid syndrome is associated with higher adjusted global antiphospholipid syndrome scores

RMD Open. 2018 Jul 13;4(2):e000693. doi: 10.1136/rmdopen-2018-000693. eCollection 2018.

Lucas L van den Hoogen^{1

2}, Giovanni Palla^{1

2}, Cornelis P J Bekker^{1

2}, Ruth D E Fritsch-Stork³, Timothy R D J Radstake^{1

2}, Joel A G van Roon^{1

2}

¹ Laboratory of Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
² Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
³ 1st Medical Department and Ludwig Boltzmann Institute of Osteology at the Hanusch Hospital of WGKK, AUVA Trauma Centre Meidling, Hanusch Hospital, Sigmund Freud University, Vienna, Austria.

No abstract available

Keywords: B cells; antiphospholipid syndrome; cytokines; systemic lupus erythematosus.